Kivenul (Ibuprofen, Paracetamol)

Ibuprofen blocks COX‑1 and COX‑2 enzymes, lowering peripheral prostaglandin production and reducing inflammation and pain. Paracetamol works centrally to inhibit prostaglandin synthesis in the brain, providing analgesic and antipyretic effects. Together they offer complementary mechanisms for enhanced symptom control.

The specific dose of Kivenul is determined by the prescribing healthcare professional based on the patient’s age, weight, and clinical condition. The prescriber will select the appropriate strength and frequency in accordance with local guidelines and product labeling.

Safety of ibuprofen/paracetamol combinations during pregnancy or lactation depends on the trimester and individual risk factors. Paracetamol is generally considered safe when used at recommended doses, whereas ibuprofen is usually avoided in the third trimester. Patients should consult their healthcare provider before use.

To place an order, submit an enquiry on the Kivenul product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with single‑ingredient ibuprofen or paracetamol tablets, Kivenul offers combined analgesic and antipyretic action, potentially achieving faster pain relief with lower individual doses. It differs from opioid analgesics, which act on central opioid receptors and carry a higher risk of dependence.

Kivenul tablets should be stored at ambient temperature, below 25 °C, in their original packaging to protect from moisture and heat. Keep the product out of reach of children and avoid storing in damp or excessively hot environments.

Kivenul is taken orally with a full glass of water. It may be taken with or without food, although taking it with food can reduce gastrointestinal discomfort. The exact dosing schedule should follow the prescriber’s instructions.

Serious adverse reactions can include severe allergic responses such as anaphylaxis, gastrointestinal bleeding or ulceration, significant liver injury especially with overdose, and renal impairment in susceptible individuals. Prompt medical attention is required if any of these events occur.

Individuals with known hypersensitivity to ibuprofen, other NSAIDs, or paracetamol should avoid Kivenul. It is also contraindicated in patients with active gastrointestinal ulcer disease, severe liver or kidney dysfunction, and in the third trimester of pregnancy unless advised by a physician.